Vion's Fate Depends On Raising Funds To Conduct New Onrigin Study
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA complete response letter requests another randomized study of the acute myeloid leukemia drug to show it is safe and increases survival in elderly patients.